Loading
Last discussed
3mo ago
Jul 18, 2026
via Biotech · 4 tagged in 12 months
Can the AI Industry Regulate Itself? Stripe Wants PayPal, China Catches Up, NY Bans Datacenters
The All-In Podcast·Jul 18, 2026
All time
16
+14 via 12 narrower
On record
14
took a position
Where they standWhere they stand
Camps of opinion · 2Positions people took on this topic in transcripts, grouped by school of thought. The bar shows each camp's share of the people sorted into a camp. It is not a poll and not a share of any audience, and people whose position fit no camp are left out of it. Within a camp, people with demonstrated expertise on the topic come first, then those who reached the most listeners on it. Positions are extracted from transcripts by a model and may misattribute who said what. Every quote links to the episode it came from.
Share of people placed in a camp5 people
60%
40%
- Reduce Regulatory Barriers3 people · 60%
- Prioritize Aging Reversal2 people · 40%
Reduce Regulatory Barriers
The biotech sector requires less regulatory oversight and streamlined processes to improve economic feasibility and innovation speed.
3 people · 3 episodes
While not explicitly arguing a position on the biotech industry itself, he maintains that the administrative state should not have the authority to unilaterally regulate industries like biotechnology
“there's a legislative branch that makes the laws there's an executive branch that enforces the laws there's a judicial branch the highest organ of which is the Supreme Court that interprets the laws what's going on with all of these bureaucracies with 4 million plus people making most of the rules t”
Shawn Ryan Show · May 2024 · 3 episodes · 2.3M views on this topic
The United States must reduce regulatory red tape and streamline clinical trials, such as centralized IRBs and single pivotal trials, to remain competitive with international biotech innovation.
“There is a race and when we came to office we were losing that race. We were behind. we were getting clocked by China, by Australia and other countries that were doing things more efficiently with less red tape”
The All-In Podcast · Jan 2026 · 1 episode · 124K views on this topicLN
Lada NuzhnaUnrated
The biotech industry has become increasingly regulated over time, which has contributed to the deteriorating economic feasibility of drug development.
“Since the birth of this industry, we only had increasing regulation over time. I think there was like only one time in history of biotech where we made it easier to develop an appropriate drug.”
a16z · Nov 2025 · 1 episode · 10K views on this topicPrioritize Aging Reversal
Advancements in biotechnology, particularly through directed evolution and cellular research, should focus on reversing the aging process.
2 people · 2 episodes
The development of novel enzymes to break down extracellular proteins is a groundbreaking application of AI and directed evolution that offers profound potential for reversing physical signs of aging.
“It's kind of a groundbreaking demonstration of combination of alphafold what's called directed evolution where you change the order of the DNA that changes the structure of the protein to test different proteins do high throughput screening and ultimately make a novel protein that doesn't exist in n”
The All-In Podcast · Jul 2026 · 9 episodes · 3.1M views on this topic
Reversing aging will treat and cure chronic diseases because aging is the fundamental driver of these conditions.
“When you reverse aging, diseases of aging go away or are cured. And in my lab, including many types of cancer as well. The diseases that we try to treat individually with different medicines today that we think are unrelated, Alzheimer's, cancer, heart disease, you name them. Fundamentally, what's d”
The Diary of a CEO · Mar 2026 · 1 episode · 6.8M views on this topicExtracted by a model; may misattribute who said what.
In the transcripts
Episodes discussing this topicIncludes episodes tagged with a narrower subject. Each is marked with the subject it came in through.
90%
Showing 10 of 30
Over time
Share of episodesThis topic's episodes as a share of every episode we analysed, in each complete month. We analyse more episodes every month, so a raw count would mostly show that growth. Recent months fill in as transcripts are analysed.
Complete months · first on record Jun 2022